Literature DB >> 23430249

Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.

Susana Infantes1, Elena Lorente, Eilon Barnea, Ilan Beer, Alejandro Barriga, Fátima Lasala, Mercedes Jiménez, Arie Admon, Daniel López.   

Abstract

The presentation of short viral peptide antigens by human leukocyte antigen (HLA) class I molecules on cell surfaces is a key step in the activation of cytotoxic T lymphocytes, which mediate the killing of pathogen-infected cells or initiate autoimmune tissue damage. HLA-B27 is a well known class I molecule that is used to study both facets of the cellular immune response. Using mass spectrometry analysis of complex HLA-bound peptide pools isolated from large amounts of HLA-B*2705(+) cells, we identified 200 naturally processed HLA-B*2705 ligands. Our analyses revealed that a change in the position (P) 2 anchor motif was detected in the 3% of HLA-B*2705 ligands identified. B*2705 class I molecules were able to bind these six GlnP2 peptides, which showed significant homology to pathogenic bacterial sequences, with a broad range of affinities. One of these ligands was able to bind with distinct conformations to HLA-B27 subtypes differentially associated with ankylosing spondylitis. These conformational differences could be sufficient to initiate autoimmune damage in patients with ankylosing spondylitis-associated subtypes. Therefore, these kinds of peptides (short, with GlnP2, and similar low affinity to all HLA-B27 subtypes tested but with unlike conformations in differentially ankylosing spondylitis-associated subtypes) must not be excluded from future researches involving potential arthritogenic peptides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430249      PMCID: PMC3624468          DOI: 10.1074/jbc.M113.455352

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility.

Authors:  Heinz Fabian; Hans Huser; Bernhard Loll; Andreas Ziegler; Dieter Naumann; Barbara Uchanska-Ziegler
Journal:  Arthritis Rheum       Date:  2010-04

Review 4.  Guilt by association: HLA-B27 and ankylosing spondylitis.

Authors:  R Benjamin; P Parham
Journal:  Immunol Today       Date:  1990-04

5.  NK susceptibility varies inversely with target cell class I HLA antigen expression.

Authors:  W J Storkus; D N Howell; R D Salter; J R Dawson; P Cresswell
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

6.  Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism.

Authors:  B Galocha; J R Lamas; J A Villadangos; J P Albar; J A López de Castro
Journal:  Tissue Antigens       Date:  1996-11

7.  The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions.

Authors:  Laura Sesma; Verónica Montserrat; Jose Ramón Lamas; Anabel Marina; Jesús Vázquez; José A López de Castro
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

8.  Clonal identity between skin and synovial tissue in a case of mycosis fungoides with polyarthritis.

Authors:  Yorick Sandberg; M'hamed El Abdouni; King H Lam; Anton W Langerak; Pieternella J Lugtenburg; Radboud J E M Dolhain; Freerk Heule
Journal:  J Am Acad Dermatol       Date:  2004-07       Impact factor: 11.527

9.  HLA-B27: a registry of constitutive peptide ligands.

Authors:  J A Lopez de Castro; I Alvarez; M Marcilla; A Paradela; M Ramos; L Sesma; M Vázquez
Journal:  Tissue Antigens       Date:  2004-05

10.  An endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.

Authors:  Yolanda Samino; Daniel Lopez; Sara Guil; Patricia de León; Margarita Del Val
Journal:  J Biol Chem       Date:  2003-10-28       Impact factor: 5.157

View more
  10 in total

Review 1.  Revisiting MHC genes in spondyloarthritis.

Authors:  Maxime Breban; Félicie Costantino; Claudine André; Gilles Chiocchia; Henri-Jean Garchon
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

2.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

3.  Human Leukocyte Antigen (HLA) B27 Allotype-Specific Binding and Candidate Arthritogenic Peptides Revealed through Heuristic Clustering of Data-independent Acquisition Mass Spectrometry (DIA-MS) Data.

Authors:  Ralf B Schittenhelm; Saranjah Sivaneswaran; Terry C C Lim Kam Sian; Nathan P Croft; Anthony W Purcell
Journal:  Mol Cell Proteomics       Date:  2016-02-29       Impact factor: 5.911

4.  Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Carlos Alvarez-Navarro; Patricia Gómez-Molina; Eilon Barnea; Miguel Marcilla; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2014-09-03       Impact factor: 5.911

5.  Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.

Authors:  Marijana Rucevic; Georgio Kourjian; Julie Boucau; Renata Blatnik; Wilfredo Garcia Bertran; Matthew J Berberich; Bruce D Walker; Angelika B Riemer; Sylvie Le Gall
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

6.  Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).

Authors:  Elena Lorente; Miguel G Fontela; Eilon Barnea; Antonio J Martín-Galiano; Carmen Mir; Begoña Galocha; Arie Admon; Pilar Lauzurica; Daniel López
Journal:  Mol Cell Proteomics       Date:  2020-04-07       Impact factor: 5.911

7.  Short peptide sequence identity between human viruses and HLA-B27-binding human 'self' peptides.

Authors:  Shipeng Sun; Tao Wang; Bo Pang; Huamin Wei; Guijian Liu
Journal:  Theory Biosci       Date:  2013-12-22       Impact factor: 1.315

8.  Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation.

Authors:  Valentina Tedeschi; Josephine Alba; Fabiana Paladini; Marino Paroli; Alberto Cauli; Alessandro Mathieu; Rosa Sorrentino; Marco D'Abramo; Maria Teresa Fiorillo
Journal:  Cells       Date:  2019-06-11       Impact factor: 6.600

9.  Intrinsic Folding Properties of the HLA-B27 Heavy Chain Revealed by Single Chain Trimer Versions of Peptide-Loaded Class I Major Histocompatibility Complex Molecules.

Authors:  Izabela Lenart; Linh-Huyen Truong; Dinh Dung Nguyen; Olga Rasiukienė; Edward Tsao; Jonathan Armstrong; Pankaj Kumar; Kirsty McHugh; Branca I Pereira; Balraj S Maan; Malgorzata A Garstka; Paul Bowness; Neil Blake; Simon J Powis; Keith Gould; Darren Nesbeth; Antony N Antoniou
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

10.  HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.

Authors:  Katja Nitschke; Alejandro Barriga; Julia Schmidt; Jörg Timm; Sergei Viazov; Thomas Kuntzen; Arthur Y Kim; Georg M Lauer; Todd M Allen; Silvana Gaudieri; Andri Rauch; Christian M Lange; Christoph Sarrazin; Thomas Eiermann; John Sidney; Alessandro Sette; Robert Thimme; Daniel López; Christoph Neumann-Haefelin
Journal:  J Hepatol       Date:  2013-08-23       Impact factor: 25.083

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.